Abstract | UNLABELLED: MATERIAL AND METHODS: RESULTS: CONCLUSIONS: 1. Renal complications of ifosfamide may appear after treatment completion. Monitoring of renal function parameters is necessary during and after treatment. 2. When protocols with cyclophosphamide (less nephrotoxic than ifosfamide) prove to be of similar efficiency, this treatment could be an alternative for patients' with renal disfunction. 3. Patients with completed ifosfamide treatment shall be qualified for repeated chemotherapy carefully due to high-risk of renal disfunction.
|
Authors | Elzbieta Rogowska, Wojciech Woźniak |
Journal | Medycyna wieku rozwojowego
(Med Wieku Rozwoj)
2004 Apr-Jun
Vol. 8
Issue 2 Pt 1
Pg. 289-95 Poland |
Vernacular Title | Niefrotoksyczność ifosfamidu ze szczególnym uwzglednieniem zespołu Fanconiego. |
PMID | 15738605
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents, Alkylating
- Ifosfamide
|
Topics |
- Acute Kidney Injury
(chemically induced, prevention & control)
- Adolescent
- Antineoplastic Agents, Alkylating
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects)
- Bone Neoplasms
(drug therapy)
- Dose-Response Relationship, Drug
- Fanconi Syndrome
(chemically induced, prevention & control)
- Female
- Humans
- Ifosfamide
(administration & dosage, adverse effects)
- Risk Factors
- Sarcoma, Ewing
(drug therapy)
- Time Factors
|